North America Neurostimulation Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The North America Neurostimulation Devices Market is Segmented by Device Type (Implantable Devices and External Devices), Application, and Geography.

Market Snapshot

North America Neurostimulation Devices Market Overview
Study Period: 2018 - 2026
Base Year: 2020
CAGR: 9.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The North American neurostimulation devices market is projected to register a CAGR 9.8% during the forecast period.

The North American neurostimulation devices market is estimated to show healthy growth, owing to the growing burden of neurological diseases and the rising demand for minimally invasive technologies.

Neurological disorders are found to be increasingly recognized as one of the most prevalent disorders, with a high burden to the patients, their families, and society. There has been a consistent increase in the overall neurological disorders patients approaching from multiple states and countries in the United States and Canada, which promotes the demand for neurostimulation devices. The various types of neurological disorders include cerebrovascular disease, Alzheimer’s disease, and others, such as dementia, migraine, epilepsy, meningitis, Parkinson's disease, multiple sclerosis, and poliomyelitis, among other major diseases.

According to an article in HuffPost, published in 2017, the neurological disorders affect around 100 million North Americans, indicating that about one-third of the total population suffers from neurological diseases, such as Alzheimer’s, multiple sclerosis, migraines, epilepsy, and spinal cord injury. Therefore, the rising prevalence of different types of neurological disorders and a recurring requirement of neuromodulation devices and therapies are attributing to the growth of the neurostimulation devices market in North America.

Scope of the Report

As per the scope of the report, neurostimulation devices are the most commonly used devices, mainly for the treatment of neurologic disorders, which aid in the delivery of electrical stimulation to intended parts of the patient’s brain, peripheral nervous system, and spinal cord. Moreover, over the past two decades, innovation in medical device technologies has been one of the primary drivers for the rapid evolution of neurostimulation systems.

By Device Type
Implantable Devices
Vagus Nerve Stimulators
Spinal Cord Stimulators
Deep Brain Stimulators
Gastric Electric Stimulators
Other Implantable Devices
External Devices
Transcranial Magnetic Stimulation (TMS)
Transcutaneous Electrical Nerve Stimulation (TENS)
Other External Devices
By Application
Parkinson's Disease
Pain Management
Other Applications
North America
United States

Report scope can be customized per your requirements. Click here.

Key Market Trends

Pain Management is Estimated to Dominate the Application Segment over the Forecast Period

Pain management has been estimated to dominate the overall market, by application, as there is a high prevalence of chronic pain disorders and the growing adoption rates of neurostimulation devices for pain management.

There is a high prevalence of chronic pain, disk surgery pain, and leg pain observed among the individuals approaching hospitals and clinics in North America. Thus, the demand for these devices is increasing, on account of patients preferring shorter hospital stay. According to the Global Health Data Exchange, in 2017, the combined global incidence of neurological disorders and chronic pain was found to be 3.97 billion, which includes Alzheimer's disease and other dementias, low back pain, stroke, traumatic brain injury, migraine, multiple sclerosis, spinal cord injury, and the Parkinson's disease.

An increasing number of new product launches and approvals of various devices to reduce chronic pain may help in accelerating the growth of the market studied.

Prevalence of Alzheimer’s Disease

Competitive Landscape

Some of the major players of the neurostimulation devices market are Medtronic, Cyberonics, Boston Scientific Corporation, and Abbott Laboratories. The major companies present in the market are focusing on product innovations, expansions, finding new markets, or innovating their core competency, in order to expand their individual market share.In April 2017, Boston Scientific announced that the first patient was successfully implanted in the PRISM (Precision Implantable Stimulator for Migraine) clinical study.

Recent Developments

In August 2021, MicroTransponder Inc. received the United States Food and Drug Administration approval for Vivistim Paired VNS System, to treat upper extremity motor deficits associated with chronic ischemic stroke.

In January 2021, Boston Scientific Corporation announced the launch of the WaveWriter Alpha, a spinal cord stimulator system in the United States.

Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Neurological Diseases

      2. 4.2.2 Rising Demand for Minimally Invasive Technologies

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Neurological Disease Treatments

      2. 4.3.2 Shortage of Skilled Healthcare Professionals

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Device Type

      1. 5.1.1 Implantable Devices

        1. Vagus Nerve Stimulators

        2. Spinal Cord Stimulators

        3. Deep Brain Stimulators

        4. Gastric Electric Stimulators

        5. Other Implantable Devices

      2. 5.1.2 External Devices

        1. Transcranial Magnetic Stimulation (TMS)

        2. Transcutaneous Electrical Nerve Stimulation (TENS)

        3. Other External Devices

    2. 5.2 By Application

      1. 5.2.1 Parkinson's Disease

      2. 5.2.2 Epilepsy

      3. 5.2.3 Depression

      4. 5.2.4 Dystonia

      5. 5.2.5 Pain Management

      6. 5.2.6 Other Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Boston Scientific Corporation

      3. 6.1.3 Cyberonics Inc.

      4. 6.1.4 Interpace Biosciences

      5. 6.1.5 Medtronic PLC

      6. 6.1.6 Neuronetics

      7. 6.1.7 NeuroPace Inc.

      8. 6.1.8 Nevro Corp.

      9. 6.1.9 Synapse Biomedical Inc.

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The North America Neurostimulation Devices Market market is studied from 2018 - 2026.

The North America Neurostimulation Devices Market is growing at a CAGR of 9.8% over the next 5 years.

Abbott Laboratories, Synapse Biomedical Inc., Boston Scientific Corporation, NeuroPace Inc., Nevro Corp. are the major companies operating in North America Neurostimulation Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!